This study develops and validates risk prediction models from the Jackson Heart Study for cardiovascular disease incidence in black adults, incorporating standard risk factors, biomarkers, and subclinical disease.
This study uses data from the Framingham Heart Study to evaluate the effect of prepregnancy elevation of low-density lipoprotein cholesterol levels on the development of dyslipidemia in adult offspring.
This study evaluates hospital-level variation to determine whether hospital process composite performance measures of in-hospital cardiac arrest care quality are associated with patient outcomes.
This study uses Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry data to develop a statistical model for prediction of in-hospital mortality after transcatheter aortic valve replacement in a national population of patients undergoing the procedure.
This cross-sectional study of outpatients with atrial fibrillation enrolled in the NCDR PINNACLE Registry examines the extent to which prescription of an oral anticoagulant in real-world US cardiology practices increases as the number of stroke risk factors increases.
This cohort study at the Department of Veterans Affairs describes the incidence of and risk factors for traumatic intracranial bleeding in a large cohort of older adults who were newly prescribed warfarin sodium.
This pooled cohort analysis of data on 48 286 patients in 4 randomized clinical trials investigates the incidence of sudden cardiac death after non–ST-segment elevation acute coronary syndrome (ACS) to develop a risk model and score for sudden cardiac death.
This cohort study assesses the echocardiographic records and cardiac structural variables of National Basketball Association professional athletes.
This study determines the prevalence of clinically silent and manifest rheumatic heart disease as a function of age, sex, and socioeconomic status and estimates age-specific incidence.
This Viewpoint discusses management of heart failure with preserved ejection fraction (HFpEF) and lessons learned from the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial.
This Viewpoint discusses patient goals–directed care as an alternative to disease-centered decision making to better align care with what matters most to patients and reduces treatment burden.
This review discusses the treatment advances that are now available to patients with hypertrophic cardiomyopathy and that have reduced disease-related mortality and improved quality of life.
A teenage girl presents with recurrent episodes of palpitations for 6 consecutive years, with right bundle branch block morphologic features that did not improve with sotalol treatment. What would you do next?
Create a personal account or sign in to: